Loading company…
Won a federal SBIR/STTR research award from HHS and other federal agencies.
DOOR PHARMACEUTICALS has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $306,500 in 2024. These are non-dilutive federal research grants, not equity financing. The company is based in BLOOMINGTON, Indiana.
No investors recorded yet for DOOR PHARMACEUTICALS.
Add an investorDOOR PHARMACEUTICALS has no recorded acquisitions.
Add an acquisitionStill private — no exit on record.
Record an exitNo diversity signals recorded yet for DOOR PHARMACEUTICALS.
Add diversity data